Leflunomide use and the risk of intersti
β
Samy Suissa; Marie Hudson; Pierre Ernst
π
Article
π
2006
π
John Wiley and Sons
π
English
β 66 KB
π 2 views
## Abstract ## Objective Spontaneous reports of interstitial lung disease (ILD) in patients with rheumatoid arthritis (RA) treated with leflunomide, a diseaseβmodifying antirheumatic drug (DMARD), have been appearing recently. To assess this risk, we conducted a populationβbased epidemiologic stud